IO Insights

View in Browser January 1, 2026 Advertisement Top Articles of 2025 SIO would like to wish its members, partners and other professionals in the industry a safe and happy holiday season. As we reflect on the past year, we would like to provide a look back at the most accessed articles from the year. Look for more of the top articles from 2025 in the Jan. 1 issue. Our regular publication will resume Thursday, Jan. 8. Percutaneous Magnetic Resonance Imaging-Guided Microwave Ablation for Patients With Cirrhosis Complicated by Small Hepatocellular Carcinoma Journal of Vascular and Interventional Radiology via ScienceDirect From Feb. 6: The study evaluated the technical effectiveness and therapeutic outcomes of percutaneous magnetic resonance-guided microwave ablation for treating small hepatocellular carcinoma in cirrhotic patients. Read More Advertisement Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy Journal of Hepatocellular Carcinoma via Taylor and Francis Online From Jul. 17: This study examines the impact of clinical factors on overall survival and progression-free survival in patients treated with drug-eluting bead transcatheter arterial chemoembolization for hepatitis B-related primary liver cancer. Read More Prediction of Early Recurrence After Bronchial Arterial Chemoembolization in Nonsmall Cell Lung Cancer Patients Using Dual-energy CT Academic Radiology via ScienceDirect Fom Sept. 18: The study explores the use of dual-energy computed tomography in predicting early recurrence after Bronchial artery chemoembolization in nonsmall cell lung cancer patients who failed first-line therapy. Read More Advertisement OPuS One Clinical Study News Promoted by Medtronic Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Learn More Prognostic Factors Influencing Outcomes in Hepatocellular Carcinoma Patients Undergoing Selective Internal Radiation Therapy Annals of Hepatology via Science Direct From Jan 2: SIRT is a promising endovascular treatment for hepatocellular carcinoma, recommended for early- and intermediate-stage HCC and advanced-stage HCC without extrahepatic metastasis. Understanding prognostic factors and optimizing technical procedures can enhance outcomes across various clinical scenarios. Read More Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-dominant Metastatic Colorectal Cancer: 10-Year Outcomes Clinical Colorectal Cancer via ScienceDirect From Mar. 20: The study evaluated the safety and efficacy of escalated-dosing Yttrium-90 transarterial radioembolization for liver-dominant metastatic colorectal cancer, revealing acceptable safety, high local disease control rates and median overall survival. Read More Ultrasound-Guided Intraoperative Liver Ablation — Retrospective Review of Indications and Outcomes Clinical Radiology via ScienceDirect From Jul. 3: This retrospective study analyzed 27 patients undergoing intraoperative ablation of 42 liver tumors from 2001 to 2021. Indications for IOA included concurrent partial hepatectomy, new tumor detection, unsafe percutaneous trajectory or clamp of hilum. Read More Nanomedicine-Unlocked Radiofrequency Dynamic Therapy Dampens Incomplete Radiofrequency Ablation-Arised Immunosuppression to Suppress Cancer Relapse Biomaterials via ScienceDirect From Jan. 16: Incomplete radiofrequency ablation can leave residual tumors and make them self-adaptable, leading to relapse. Radiofrequency dynamic therapy has been developed using a modified Fe-based single atom nanozyme, which produces reactive oxygen species, enhancing the therapy. Read More Radiation Segmentectomy for Early Hepatocellular Carcinoma is Curative Journal of Hepatology via PubMed From Feb. 20: The RADSEG method, a curative technique for limited-disease burden hepatocellular carcinoma, offers a more efficient alternative to current treatments due to organ availability and tumor size limitations. Read More Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients With Stable HCC Cancers via PubMed From Jan. 30: The study investigated the effectiveness of adding locoregional therapy to atezolizumab and bevacizumab in patients with stable disease HCC, evaluating the response rate and initial antitumor effect of the combination therapy. Read More A Vascular Heterogeneity-Orienting TACE Strategy Addresses Peripheral Tumor and Avascular Deep Tumor for Complete Hepatocellular Carcinoma Clearance Chemical Engineering Journal via ScienceDirect From Apr. 10: The study developed a photothermal-triggered TACE embolization agent to improve the prognosis of hepatocellular carcinoma treatment by enhancing drug transport and reducing hypoxic conditions. Read More IO Insights The Society of Interventional Oncology 2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA 202-367-1164 | Contact Us www.sio-central.org Mykaila Potts Content Editor, Multiview 972-910-6876 | Contact me Unsubscribe | Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE | SUBSCRIBE | PAST ISSUES Published by